Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Toonaangevende leiders

HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van bedrijfsleiders 
Portrait de Chaim Hurvitz
Leeftijd : 62
Vermogen : 6 327 315 USD
Belangrijkste bedrijven : NRx Pharmaceuticals, Inc. - PolyPid Ltd. - Univo Pharmaceuticals Ltd
Overzicht 
Chaim Hurvitz is an Israeli businessperson who founded CH Health and who has been the head of 8 different companies. Presently, he occupies the position of Chairman at Univo Pharmaceuticals Ltd., Chairman of Aerodentis, Chairman of Dror Ortho-Design Ltd. and Chief Executive Officer for CH Health.

He is also Chairman for The Institute for the Advancement of Education in Jaffa, Head-Pharmaceutical Branch at Manufacturers Association of Israel and Member of Israel Diamond Manufacturers Association Ltd. and on the board of 8 other companies.

In his past career Chaim Hurvitz occupied the position of Chairman for Galmed Pharmaceuticals Ltd. and Director at Teva Pharmaceutical Industries Ltd. and President & Chief Executive Officer of Teva Pharmaceuticals Europe BV (a subsidiary of Teva Pharmaceutical Industries Ltd.).

Chaim Hurvitz received an undergraduate degree from Tel-Aviv University.


Posities en verantwoordelijkheden van Chaim Hurvitz 
NaamTitel Van
NRx Pharmaceuticals, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2021
PolyPid Ltd.
(Farmaceutische producten)
Independent Director 2017
Univo Pharmaceuticals Ltd
(Biotechnologie & Medisch Onderzoek)
Chairman 2019
CH Health Chief Executive Officer 2011
The Institute for the Advancement of Education in Jaffa Chairman -
Aerodentis Chairman -
Galmed Medical Research Ltd. Director -
Genoscience Pharma Director -
Shirat Hachaim Ltd. Director -
NeuroRx, Inc. Director 2015
Celixir Plc Director -
MyBiotics Pharma Ltd. Director 2018
Dror Ortho-Design Ltd. Chairman -
Manufacturers Association of Israel Head-Pharmaceutical Branch -
Israel Diamond Manufacturers Association Ltd. Member 2006


Belangnemingen van Chaim Hurvitz 
NaamAandelen%Totale waarde
PolyPid Ltd. (PYPD)
(Farmaceutische producten)
873 4554,49%5 258 199 USD
NRx Pharmaceuticals, Inc. (NRXP)
(Biotechnologie & Medisch Onderzoek)
1 644 7932,43%1 069 115 USD


Chaim HurvitzPersoonlijk netwerk 
Meest gelezen nieuws 
29/09Buffett's Berkshire Hathaway koopt 5,99 mln extra aandelen Occidental
MR
26/09De soap van Unilever: Fusies en overnames, banenreducties, Nelson Peltz in de raad van bestuur
MR
05/10Musk zegt dat Twitter-deal 'versneller' is om 'alles-app' te creëren
MR
26/09Twitter interviewt Elon Musk, bekend om strijdlustige getuigenissen
MR
28/09Elon Musk wil toestemmingsovereenkomst SEC versmallen, einde aan voorafgaande goedkeuring van tweets
MR
29/09De lange, bochtige weg naar de beursgang van Volkswagen's Porsche
MR
26/09Getuigenissen van Musk, Twitter's Agrawal zijn uitgesteld - bronnen
MR
22/09Boeing betaalt 200 miljoen dollar om civiele beschuldigingen te schikken dat het investeerders misleidde over 737 MAX
MR
Meer nieuws


© 2022 People and Ownership :   
Chaim Hurvitz Verbindingen